Related Posts

• 
  CPTR Newsletter – April 2018
• Helmsley Charitable Trust Awards Critical Path Institute a Grant to Focus on Crohn’s Disease Biomarkers
• 
  C-Path and CHDI launch consortium to accelerate development of Huntington’s disease therapies
• 
  Global Health Partners Accelerate Uptake of Genetic Sequencing for Surveillance And Diagnosis Of Drug-Resistant Tuberculosis
• 
  Towards Bridging Translational Gap in Cardiotoxicity Prediction: an Application of Progressive Cardiac Risk Assessment Strategy in TdP Risk Assessment of Moxifloxacin